Fulgent Genetics (FLGT) Stock Statistics & Valuation Metrics

Fulgent Genetics has a market cap or net worth of $545.09M. The enterprise value is $454.27M.

Fulgent Genetics has 30.87M shares outstanding. The number of shares has decreased by -2.65% in one year.

Fulgent Genetics’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -5.43%.

The current PE Ratio of Fulgent Genetics is -13.08. Fulgent Genetics’s PEG ratio is 0.17.

In the last 12 months, Fulgent Genetics had revenue of $283.47M and earned -$42.71M in profits. Earnings per share was -$1.41.

In the last 12 months, operating cash flow was $21.06M and capital expenditures -$40.31M, giving a free cash flow of -$19.25M billion.

Fulgent Genetics pays an annual dividend of , resulting in a dividend yield of

Fulgent Genetics upcoming earnings date is May 2, 2025, After Close.

Fulgent Genetics as a current ratio of 4.85, with Debt / Equity ratio of <0.01

In the past 12 months, Fulgent Genetics has paid -$8.14M in taxes.

Fulgent Genetics EV to EBITDA ratio is -6.81, with an EV/FCF ratio of -26.16.

Fulgent Genetics has $258.11M in cash and marketable securities with $8.47M in debt, giving a net cash position of -$249.64M billion.

Gross margin is 37.82%, with operating margin of -26.08%, and net profit margin of -15.07%.

The average price target for Fulgent Genetics is $18.00, which is 11.43% higher than the current price. The consensus rating is Hold